With September Cool Comes Three Big Concerns
I’m looking forward to a break from the heat, but not to these economic worries that could add to already poor seasonality.
I’m looking forward to a break from the heat, but not to these economic worries that could add to already poor seasonality.
These names carried the market on Friday as a choppy decline looms ahead.
A scheduled decline in prescription drug prices gives Target a sustainable edge over Walmart.
Wednesday’s bond relief and biotech celebration lasted exactly one session.
China would rather you focus on its tech sector than the conclusion of its Evergrande saga. But should you?
As the market quickly forgets a significant Treasury buyback, the retail giant offered a concerning economic update.
The indices held up on one biotech breakthrough while the Nasdaq lost ground.
The negative seasonality I have been anticipating finally kicked in on Tuesday.
U.S. investors may have to wait to get their hands on shares of Unitree Robotics.
Rotational action masked severe weakness as trading slowed.